Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Leukemia|July 28, 2025
High glutamate levels in the bone marrow of multiple myeloma patients promote osteoclast formation: a novel target for osteolytic bone diseaseDenise Toscani, Oxana Lungu, Martina Chiu, et al.Experimental Hematology|December 8, 2009
Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone diseaseKatia Todoerti, Gina Lisignoli, Paola Storti, et al.Annals of Hematology|May 19, 2026
Long-term prognostic impact of chromosome 1 abnormalities in newly diagnosed multiple myeloma patients: a monocentric studyNicolas Thomas Iannozzi, Gabriella Sammarelli, Andrea Poletti, et al.Haematologica|March 26, 2026
Oncolytic bovine herpesvirus type 1 induces immune microenvironment remodeling and enhances treatment responses in multiple myelomaVincenzo Raimondi, Rosanna Vescovini, Paola Storti, et al.Haematologica|January 7, 2017
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclastsMarina Bolzoni, Domenica Ronchetti, Paola Storti, et al.Blood|June 9, 2016
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive targetMarina Bolzoni, Martina Chiu, Fabrizio Accardi, et al.Cancer Gene Therapy|July 10, 2026
PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progressionNicolas Thomas Iannozzi, Paola Storti, Rosanna Vescovini, et al.Journal of Hematology & Oncology|November 14, 2025
B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escapeArne Van der Vreken, Fien Meeus, Chenggong Tu, et al.Cancers|November 10, 2020
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine AvailabilityMartina Chiu, Denise Toscani, Valentina Marchica, et al.Cancer Cell|July 4, 2017
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple MyelomaMatteo Marchesini, Yamini Ogoti, Elena Fiorini, et al.Pageof 5